Physician

Michael John Ford, M.D.

According to 2025 Medicare claims, Michael Ford, M.D. (NPI: 1508868860) practices dermatology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is SOUTHEASTERN DERMATOLOGY, PA (NPI: 1841229036; TIN: 593737893) and primary practice location at 32308-4599.

Ford's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,336 traditional Medicare patients, billed 11,892 HCPCS/CPT codes, and received $939,618 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,234 prescription claims across 691 beneficiaries totaling $385,243 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 76 records totaling $1,413. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $255,076 to $385,243. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$470K$940K2015 Medicare payment: $752,738 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $723,612 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $700,907 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $756,115 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $757,501 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $719,870 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $748,809 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $788,503 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $926,537 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $939,618 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,19710,712$752,738
20161,20710,179$723,612
20171,30510,895$700,907
20181,31610,609$756,115
20191,31113,900$757,501
20201,2319,593$719,870
20211,30210,236$748,809
20221,24810,043$788,503
20231,35111,597$926,537
20241,33611,892$939,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$251K$502K2015 Drug cost: $255,076 (USD; Tot_Drug_Cst)2016 Drug cost: $204,665 (USD; Tot_Drug_Cst)2017 Drug cost: $164,427 (USD; Tot_Drug_Cst)2018 Drug cost: $227,373 (USD; Tot_Drug_Cst)2019 Drug cost: $313,778 (USD; Tot_Drug_Cst)2020 Drug cost: $498,861 (USD; Tot_Drug_Cst)2021 Drug cost: $502,497 (USD; Tot_Drug_Cst)2022 Drug cost: $354,561 (USD; Tot_Drug_Cst)2023 Drug cost: $322,833 (USD; Tot_Drug_Cst)2024 Drug cost: $385,243 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20159012,418$255,076
20169422,400$204,665
20177851,923$164,427
20186381,422$227,373
20196701,437$313,778
20205681,165$498,861
20216041,107$502,497
20226281,094$354,561
20236671,217$322,833
20246911,234$385,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths332390$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9721,477$61
88305Pathology examination of tissue using a microscope, intermediate complexity595914$53
17000Destruction of precancer skin growth, 1 growth619858$35
17003Destruction of precancer skin growth, 2-14 growths4552,447$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab36994$137,205
Clobetasol PropionateClobetasol Propionate1233,628$4,828
Doxycycline HyclateDoxycycline Hyclate4663,117$3,291
ImiquimodImiquimod883,265$2,363
MetronidazoleMetronidazole15505$967

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.76$1,413ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael John Ford, M.D.?

Tedicare shows public-source Medicare data for Michael John Ford, M.D. (NPI 1508868860), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael John Ford, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael John Ford, M.D.?

Michael John Ford, M.D. is linked to SOUTHEASTERN DERMATOLOGY, PA (billing NPI 1841229036) in the available physician profile data.

Does Michael John Ford, M.D. have Open Payments data?

Michael John Ford, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.